Senate Bill S1001A

Signed By Governor
2023-2024 Legislative Session

Prohibits insurers from restricting or imposing delays in the distribution of antiretroviral prescription drugs prescribed to a person for HIV or AIDS

download bill text pdf

Sponsored By

Current Bill Status - Signed by Governor


  • Introduced
    • In Committee Assembly
    • In Committee Senate
    • On Floor Calendar Assembly
    • On Floor Calendar Senate
    • Passed Assembly
    • Passed Senate
  • Delivered to Governor
  • Signed By Governor

Do you support this bill?

Please enter your contact information

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.
Actions
Votes

Bill Amendments

co-Sponsors

2023-S1001 - Details

See Assembly Version of this Bill:
A1619
Law Section:
Insurance Law
Laws Affected:
Amd §§3216, 3221 & 4303, Ins L
Versions Introduced in 2021-2022 Legislative Session:
S8423, A9580

2023-S1001 - Summary

Prohibits insurers from restricting or imposing delays in the distribution of antiretroviral prescription drugs prescribed to a person for the treatment or prevention of the human immunodeficiency virus (HIV) or acquired immunodeficiency syndrome (AIDS).

2023-S1001 - Sponsor Memo

2023-S1001 - Bill Text download pdf

                             
                     S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                   1001
 
                        2023-2024 Regular Sessions
 
                             I N  S E N A T E
 
                              January 9, 2023
                                ___________
 
 Introduced  by  Sens.  HOYLMAN, MYRIE, SALAZAR -- read twice and ordered
   printed, and when printed to be committed to the Committee on Health
 
 AN ACT to amend the public health law, in relation  to  prohibiting  the
   preferred  drug  program  from  restricting  or imposing delays in the
   distribution of antiretroviral prescription drugs to certain  persons;
   to  amend  the social services law, in relation to prohibiting managed
   care programs from restricting or imposing delays in the  distribution
   of  antiretroviral prescription drugs to certain persons; and to amend
   the insurance law, in relation to prohibiting insurers from  restrict-
   ing   or   imposing  delays  in  the  distribution  of  antiretroviral
   prescription drugs to certain persons
 
   THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
   Section 1. Section 273 of the public health law is amended by adding a
 new subdivision 11 to read as follows:
   11.  NO  PRIOR AUTHORIZATION, STEP THERAPY, OR ANY OTHER PROTOCOL THAT
 COULD RESTRICT OR DELAY THE DISPENSING OF THE DRUG SHALL BE REQUIRED FOR
 ANTIRETROVIRAL PRESCRIPTION DRUGS PRESCRIBED TO  A  PERSON  IN  A  STATE
 PUBLIC  HEALTH PLAN FOR THE TREATMENT OR PREVENTION OF THE HUMAN IMMUNO-
 DEFICIENCY VIRUS (HIV) OR ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS).
   § 2. Section 364-j of the social services law is amended by  adding  a
 new subdivision 26-d to read as follows:
   26-D.  MANAGED  CARE  PROVIDERS  SHALL  NOT  SUBJECT AN ANTIRETROVIRAL
 PRESCRIPTION DRUG PRESCRIBED TO A PERSON FOR THE TREATMENT OR PREVENTION
 OF THE HUMAN IMMUNODEFICIENCY VIRUS (HIV) OR  ACQUIRED  IMMUNODEFICIENCY
 SYNDROME  (AIDS)  TO A PRIOR AUTHORIZATION REQUIREMENT, STEP THERAPY, OR
 ANY OTHER PROTOCOL THAT COULD RESTRICT OR DELAY THE  DISPENSING  OF  THE
 DRUG.
   § 3. Subsection (i) of section 3216 of the insurance law is amended by
 adding a new paragraph 39 to read as follows:
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                       [ ] is old law to be omitted.
                                                            LBD04099-01-3
 S. 1001                             2
              

co-Sponsors

2023-S1001A (ACTIVE) - Details

See Assembly Version of this Bill:
A1619
Law Section:
Insurance Law
Laws Affected:
Amd §§3216, 3221 & 4303, Ins L
Versions Introduced in 2021-2022 Legislative Session:
S8423, A9580

2023-S1001A (ACTIVE) - Summary

Prohibits insurers from restricting or imposing delays in the distribution of antiretroviral prescription drugs prescribed to a person for the treatment or prevention of the human immunodeficiency virus (HIV) or acquired immunodeficiency syndrome (AIDS).

2023-S1001A (ACTIVE) - Sponsor Memo

2023-S1001A (ACTIVE) - Bill Text download pdf

                             
                     S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                  1001--A
     Cal. No. 164
 
                        2023-2024 Regular Sessions
 
                             I N  S E N A T E
 
                              January 9, 2023
                                ___________
 
 Introduced by Sens. HOYLMAN-SIGAL, MAY, MYRIE, SALAZAR -- read twice and
   ordered  printed, and when printed to be committed to the Committee on
   Health -- recommitted to the Committee on Health  in  accordance  with
   Senate  Rule  6,  sec.  8  --  reported favorably from said committee,
   ordered to first and second report, ordered to a third reading, passed
   by Senate and delivered to the Assembly, recalled, vote  reconsidered,
   restored  to  third  reading, amended and ordered reprinted, retaining
   its place in the order of third reading
 
 AN ACT to amend the insurance law, in relation to  prohibiting  insurers
   from  restricting or imposing delays in the distribution of antiretro-
   viral prescription drugs to certain persons
 
   THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
   Section  1.  Subsection  (i)  of  section 3216 of the insurance law is
 amended by adding a new paragraph 39 to read as follows:
   (39) NO POLICY THAT PROVIDES COVERAGE FOR ANTIRETROVIRAL  PRESCRIPTION
 DRUGS  PRESCRIBED FOR THE TREATMENT OR PREVENTION OF THE HUMAN IMMUNODE-
 FICIENCY VIRUS (HIV) OR ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS)  SHALL
 SUBJECT SUCH DRUGS TO PRIOR AUTHORIZATION.
   § 2. Subsection (l) of section 3221 of the insurance law is amended by
 adding a new paragraph 22 to read as follows:
   (22) EVERY GROUP OR BLANKET POLICY DELIVERED OR ISSUED FOR DELIVERY IN
 THIS  STATE THAT PROVIDES COVERAGE FOR ANTIRETROVIRAL PRESCRIPTION DRUGS
 FOR THE TREATMENT OR PREVENTION  OF  THE  HUMAN  IMMUNODEFICIENCY  VIRUS
 (HIV)  OR  ACQUIRED  IMMUNODEFICIENCY  SYNDROME (AIDS) SHALL NOT SUBJECT
 SUCH DRUG TO A PRIOR AUTHORIZATION REQUIREMENT.
   § 3. Section 4303 of the insurance law is  amended  by  adding  a  new
 subsection (vv) to read as follows:
   (VV) ANY CONTRACT ISSUED BY A MEDICAL EXPENSE INDEMNITY CORPORATION, A
 HOSPITAL  SERVICE  CORPORATION  OR  A  HEALTH  SERVICES CORPORATION THAT
 PROVIDES COVERAGE FOR ANTIRETROVIRAL PRESCRIPTION DRUGS FOR  THE  TREAT-
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                       [ ] is old law to be omitted.
              

Comments

Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.

Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.

Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.